Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era

2003/01/30 by Caroline Trotter, Ray Borrow, Nick Andrews +1 · 13 citations
Immunology and Microbiology · Medicine · #Antibody #Bacteria #Bacterial Infections and Vaccines #Biology #Carriage #Conjugate vaccine #Immunization #Immunology #Incidence (geometry) #Infectious Encephalopathies and Encephalitis #Medicine #Meningococcal disease #Meningococcal vaccine #Neisseria meningitidis #Pneumonia and Respiratory Infections #Serology #Seroprevalence #Titer #Vaccination #Virology

paper · doi:10.1016/s0264-410x(02)00630-8

openalex publication_date 2003/01/30 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/23

Cited by

• Meningococcal surrogates of protection?serum bactericidal antibody activity
• Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005
• Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine
• Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America. [europepmc]
• Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age. [europepmc]
• Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine. [europepmc]
• Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents. [europepmc]
• Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children. [europepmc]
• Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel. [europepmc]
• Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16. [europepmc]
• A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines. [europepmc]
• The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta. [europepmc]
• Preventing invasive meningococcal disease in early infancy. [europepmc]